CMND-100 Completes Phase I/II Part A in Alcohol Use Disorder Trial
Clearmind Medicine has finished treating all Part A participants in its Phase I/II study of CMND-100, a novel nonhalluc…
Clearmind Medicine has finished treating all Part A participants in its Phase I/II study of CMND-100, a novel nonhalluc…
Rapid Nutrition is using AI-powered commercial intelligence to accelerate its Premium Nutrition Pantry brand portfolio,…
Nordic Naturals is positioning omega-3s as essential pediatric nutrients this back-to-school season, citing their estab…
New MarketsandMarkets data quantifies accelerating marine collagen adoption across nutraceuticals and functional foods,…
McCormick's planned combination with Unilever Foods will organize into four commercial divisions — including a $2.5 bil…
Dr. Jenna Macciochi's consumer-facing guidance challenges the live-probiotic default, spotlighting stability, survivabi…
Life Extension's latest cognitive formula targets verbal memory, visual memory, processing speed, and multitasking capa…
Spindle Muscle+ from Samyang Roundsquare is the first postbiotic supplement positioned around the gut–muscle connection…
Functional ingredient innovation in alternative flours—almond, cassava, chickpea, oat—is driving mainstream adoption be…
South Korean ingredient giant debuts allulose and encapsulation tech at IFT FIRST, addressing rising demand for sugar a…
MANE's exclusive deal for bioengineered Reb M removes taste barriers to mainstream sugar-free product reformulation.
BienRaíz expands its daily wellness portfolio with a chelated magnesium format favored for superior gastrointestinal to…